Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Evan D. Bander"'
Publikováno v:
Journal of Neuro-Oncology. 158:393-403
Publikováno v:
World Neurosurgery. 154:214-221
The glioma microenvironment is heavily infiltrated by non-neoplastic myeloid cells, including bone marrow-derived macrophages and central nervous system-resident microglia. As opposed to executing the antitumor functions of immune surveillance, antig
Publikováno v:
World Neurosurgery. 154:228-231
Glioblastoma (GBM) is the most aggressive primary tumor of the central nervous system. Despite aggressive multimodal therapy, it has a dismal prognosis. Over the last 20 years, the approach to GBM research and therapy has involved viewing the patholo
Autor:
Nelson S Moss, Anne S. Reiner, Andrew L.A. Garton, Melissa Yuan, Evan D Bander, Viviane Tabar, Katherine S. Panageas, Cameron Brennan
Publikováno v:
J Neurooncol
BACKGROUND: Leptomeningeal metastasis (LM) occurs in 3–5% of patients with solid metastatic tumors and often portends a severe prognosis including symptomatic hydrocephalus and intracranial hypertension. Cerebrospinal fluid (CSF) shunting can provi
Autor:
Neeta Pandit-Taskar, Rowena Thomson, Mark M. Souweidane, Eva Wembacher-Schroeder, Nicole Kerstein, Evan D. Bander
Publikováno v:
Journal of Neurosurgery: Pediatrics. :1-9
OBJECTIVE With increasing use of convection-enhanced delivery (CED) of drugs, the need for software that can predict infusion distribution has grown. In the context of a phase I clinical trial for pediatric diffuse intrinsic pontine glioma (DIPG), CE
Autor:
Anne S. Reiner, Melissa Yuan, Katherine S. Panageas, Viviane Tabar, Evan D Bander, Nelson S Moss, Joseph A. Carnevale, Michael A. Postow
Publikováno v:
Cancer
BACKGROUND Historically, the prognosis for patients who have melanoma brain metastasis (MBM) has been dismal. However, breakthroughs in targeted and immunotherapies have improved long-term survival in those with advanced melanoma. Therefore, MBM pres
Autor:
Evan D. Bander, Andrew L.A. Garton, Luca Pasquini, Onur Yildirim, Ahmet Ilica, Morgan E. Freret, Maria Donzelli, Sofia Haque, Mark M. Souweidane
Publikováno v:
Neurosurgery. 69:38-38
Autor:
Chetan Bettegowda, Evan D. Bander, Manish K. Aghi, Jason P. Sheehan, Jonathan H. Sherman, Rohan Ramakrishna
Publikováno v:
Journal of Neuro-Oncology. 151:361-366
Evidence-based medicine guidelines are increasingly published and sanctioned by organized neurosurgery. However, implementation, interpretation, and use of clinical guidelines may vary substantially on a regional, national and international basis. Su
Autor:
Iryna Ivasyk, Alexander D Ramos, Evan D Bander, Mark M. Souweidane, Rowena Thomson, Eva Wembacher-Schroeder, Peter F. Morgenstern
Publikováno v:
Journal of Neurosurgery: Pediatrics. 26:661-666
OBJECTIVEWhile the safety and efficacy of convection-enhanced delivery (CED) have been studied in patients receiving single-dose drug infusions, agents for oncological therapy may require repeated or chronic infusions to maintain therapeutic drug con
Autor:
Prajwal Rajappa, Kenneth W Eng, Rohan Bareja, Evan D Bander, Melissa Yuan, Alisha Dua, Uday Bhanu Maachani, Matija Snuderl, Heng Pan, Tuo Zhang, Umberto Tosi, Iryna Ivasyk, Mark M Souweidane, Olivier Elemento, Andreas Sboner, Jeffrey P Greenfield, David J Pisapia
Publikováno v:
Neuro-oncology advances. 4(1)
Background As our molecular understanding of pediatric central nervous system (CNS) tumors evolves, so too do diagnostic criteria, prognostic biomarkers, and clinical management decision making algorithms. Here, we explore the clinical utility of wid